Clinical Trial Update: Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating N-acetylcysteine for patients with the m.3243A>G mitochondrial DNA mutation and low brain glutathione; currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitochondrial Disease

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Michio Hirano, MD | Conditions: Mitochondrial Disease | Phase 1 | Status: RECRUITING